期刊文献+

Caecal pH is a biomarker of excessive colonic fermentation 被引量:1

Caecal pH is a biomarker of excessive colonic fermentation
下载PDF
导出
摘要 AIM: To ascertain whether caecal pH is different in patients with irritable bowel syndrome (IBS), whose primary symptoms are bloating and distension, to healthy controls. AIM:To ascertain whether caecal pH is different in patients with irritable bowel syndrome(IBS),whose primary symptoms are bloating and distension,to healthy controls.METHODS:Motility and pH data were reviewed from16 patients with RomeⅢdefined IBS and 16 healthy controls,who had undergone a wireless motility capsule(WMC)study using a standardized protocol.Motility measures were anchored around known anatomical landmarks as identified by compartmental pH changes.Sixty-minute epochs were used to quantify antral,duodenal,ileal,caecal and distal colonic contractility.The maximum and minimum pH was measured either side of the ileo-caecal junction.RESULTS:No differences were seen in motility parameters,compartmental transit times or maximal ileal pH between the two groups.Caecal pH was significantly lower in patients compared to controls(5.12±0.05vs 6.16±0.15,P<0.0001).The ileal:caecalΔchange was greater in patients than controls(-2.63±0.08 vs-1.42±0.11,P<0.0001).There was a significant correlation between caecal pH and right colonic contractility(r=0.54,P=0.002).CONCLUSION:Patients with bloating and distension have a lower caecal pH compared to controls.The measurement of caecal pH using the WMC provides a quantifiable biomarker of fermentation potentially identifying those patients that may preferentially benefit from antibiotic or dietary interventions.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第17期5000-5007,共8页 世界胃肠病学杂志(英文版)
基金 Supported by A Grant from the SmartPill Corporation
关键词 Caecal pH Caecoparesis BLOATING Colonic microbiota FERMENTATION Caecal pH Caecoparesis Bloating Colonic microbiota
  • 相关文献

参考文献11

  • 1Sofia Tedelind,Fredrik Westberg,Martin Kjerrulf,Alexander Vidal.Anti-inflammatory properties of the short-chain fatty acids acetate and propionate:A study with relevance to inflammatory bowel disease[J].World Journal of Gastroenterology,2007,13(20):2826-2832. 被引量:84
  • 2Jian Shen,Martin S. Obin,Liping Zhao.The gut microbiota, obesity and insulin resistance[J]. Molecular Aspects of Medicine . 2012
  • 3Qing Shen,Lu Zhao,Kieran Tuohy.High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro[J].European Journal of Nutrition.2012(6)
  • 4C.Tana,Y.Umesaki,A.Imaoka,T.Handa,M.Kanazawa,S.Fukudo.Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome[J].Neurogastroenterology & Motility.2010(5)
  • 5I.SAROSIEK,K. H.SELOVER,L. A.KATZ,J. R.SEMLER,G. E.WILDING,J. M.LACKNER,M. D.SITRIN,B.KUO,W. D.CHEY,W. L.HASLER,K. L.KOCH,H. P.PARKMAN,J.SAROSIEK,R. W.MCCALLUM.The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology[J].Alimentary Pharmacology & Therapeutics.2009(2)
  • 6Anurag Agrawal,Lesley A. Houghton,Richard Lea,Julie Morris,Brian Reilly,Peter J. Whorwell.Bloating and Distention in Irritable Bowel Syndrome: The Role of Visceral Sensation[J].Gastroenterology.2008(7)
  • 7A.Agrawal,P. J.Whorwell.Abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and possible mechanisms: authors’ reply[J].Alimentary Pharmacology & Therapeutics.2008(8)
  • 8Young K. Choi,Nancy Kraft,Bridget Zimmerman,Michelle Jackson,Satish S.C. Rao.Fructose Intolerance in IBS and Utility of Fructose-Restricted Diet[J].Journal of Clinical Gastroenterology.2008(3)
  • 9Hyo JungPark,MonicaJarrett,KevinCain,MargaretHeitkemper.Psychological distress and GI symptoms are related to severity of bloating in women with irritable bowel syndrome[J].Res Nurs Health.2008(2)
  • 10N. B.Dass,A. K.John,A. K.Bassil,C. W.Crumbley,W. R.Shehee,F. P.Maurio,G. B. T.Moore,C. M.Taylor,G. J.Sanger.The relationship between the effects of short‐chain fatty acids on intestinal motility in vitro and GPR43 receptor activation[J].Neurogastroenterology & Motility.2006(1)

二级参考文献40

  • 1[24]Niederman R,Zhang J,Kashket S.Short-chain carboxylicacid-stimulated,PMN-mediated gingival inflammation.Crit Rev Oral Biol Med 1997; 8:269-290
  • 2[25]Nakao S,Moriya Y,Furuyama S,Niederman R,Sugiya H.Propionic acid stimulates superoxide generation in human neutrophils.Cell Biol Int 1998; 22:331-337
  • 3[26]Le Poul E,Loison C,Struyf S,Springael JY,Lannoy V,Decobecq ME,Brezillon S,Dupriez V,Vassart G,Van Damme J,Parmentier M,Detheux M.Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.J Biol Chem 2003; 278:25481-25489
  • 4[27]Yin L,Laevsky G,Giardina C.Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.J Biol Chem 2001; 276:44641-44646
  • 5[28]Butzner JD,Parmar R,Bell CJ,Dalal V.Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.Gut 1996; 38:568-573
  • 6[29]Okamoto T,Sasaki M,Tsujikawa T,Fujiyama Y,Bamba T,Kusunoki M.Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats.J Gastroenterol 2000; 35:341-346
  • 7[30]Uchida M,Mogami O.Milk whey culture with Propionibacterium freudenreichii ET-3 is effective on the colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats.J Pharmacol Sci 2005;99:329-334
  • 8[31]Tarrerias AL,Millecamps M,Alloui A,Beaughard C,Kemeny JL,Bourdu S,Bommelaer G,Eschalier A,Dapoigny M,Ardid D.Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats.Pain 2002; 100:91-97
  • 9[32]Gupta SK,Rastogi S,Prakash J,Joshi S,Gupta YK,Awor L,Verma SD.Anti-inflammatory activity of sodium pyruvate--a physiological antioxidant.Indian J Physiol Pharmacol 2000; 44:101-104
  • 10[33]Fink MP.Ethyl pyruvate:a novel anti-inflammatory agent.Crit Care Med 2003; 31:S51-S56

共引文献87

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部